- Global Pharma News & Resources

Global Blood Screening Market 2020:Covid-19 Impact Analyis,Growth Opportunities, Industry Analysis,Outlook,Forecast To 2027||Players-Enzo Biochem Inc., Meridian Bioscience, Inc., BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., BioMérieux SA

Global Blood screening Market–Industry Trends and Forecast to 2027” New Research Report Added to database. The report width Of pages : 350  Figures: 60 And Tables: 220 in it.The global Blood screening market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of Blood screening market for global, Europe, North America, Asia Pacific and South America.

Blood screening market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to grow with a CAGR of 5.75% in the above-mentioned forecast period. The growing awareness amongst the patients regarding the donation of blood to a serious patient will help in driving the growth of the blood screening market.

Download Free Sample (350 Pages PDF, Full TOC, List of Tables & Figures, and Chart) Report @

Key Market Competitors Covered in the report

  • Hoffmann-La Roche Ltd
  • Abbott
  • Thermo Fisher Scientific Inc.
  • Siemens AG
  • Bio-Rad Laboratories, Inc.
  • BD
  • Beckman Coulter, Inc.
  • bioMérieux SA
  • Enzo BiochemInc.
  • Hologic Inc.
  • Ortho Clinical Diagnostics
  • Meridian Bioscience, Inc
  • Immucor, Inc.

Global Blood Screening Market Scope and Market Size

Blood screening market is segmented on the basis of products & services, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of products & services segment, the blood screening market is segmented into reagents and kits, instruments and software & services. Reagents and kits are further sub-segmented into NAT reagents & kits, ELISA reagents & kits others as well. NAT reagents is further sub-segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labelling and detection reagents. ELISA reagents & kits is further sub-segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments and purchase type.

On the basis of technology, the blood screening market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub-segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA market, by platform is further sub-segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above.

On the basis of disease type segment, the blood screening market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others.

The end user segment in the blood screening market is segmented into diagnostic centers, blood bank, hospitals, clinics and ambulatory surgical centers.

To Understand How Covid-19 Impact Is Covered In This Report, Get Free Covid-19 Sample @

Blood Screening Market Development

Roche announced the launch of their new blood screening test cobbas Zika test in December 2019. This new test is consistent with the cobas 6800/8800 systems, which is designed for use in blood donation screening. This launch will help the company to enhance their reach in the market and also decreases the risk of transmission via plasma donation and infected blood.

Global Blood Screening Market Drivers:

The growing awareness amongst the patients regarding the donation of blood to a serious patient will help in driving the growth of the blood screening market.

Rising occurrences of new form of pathogens, surging levels of investment for the development of advanced technology, growing geriatric population, favourable policies of the government regarding blood screening will likely to quicken the growth of the blood screening market in the forecast period of 2020-2027.

On the other hand, growing healthcare sector along with increasing technological advancement will further boost various opportunities that will lead to the growth of the blood screening market in the above mentioned forecast period.

Opportunity: Global Blood Screening Market


The screening of blood involves the process that ensures whether the blood collected from people are safe or not. Based on the results of the screening, collected blood units are released for clinical research purpose or discarded if it has some contamination of bacteria or viruses or any other. For performing such screening there are different assays that help in determining the proper result.

Further with advancement, many of the other techniques are introduced with high benefits helping the market to grow in the upcoming days. The techniques are microbial screening and multiplexing technology.

Thermo Fisher Scientific (U.S.) provides microbial isolation and screening which include blood culture systems, clinical microbial identification, and microbiology specimen collection

In August 2015, Eurofins (France) launched accredited NGS tests useful for the identification of non-targeted microorganism. It helps in 16S rDNA screening for identifying the presence of microorganism communities in sample.

In July 2017, July 18, 2017–BD (Becton, Dickinson and Company) (U.S.) introduced new technologies which can automatically report and release negative urine cultures. This technology is transformed in the form of microbiology urine testing.

For More Information or Query or Customization before Buying, Visit @

Points Covered in The Report:

The points that are discussed within the report are the major market players that are involved in the Blood screening market.

The complete profile of the companies is mentioned.

The production, sales, future strategies, and the technological developments that they are making are also included within the report.

The growth factors of the Blood screening market is discussed in detail wherein the different end users of the market are explained in detail.

The application areas of the Blood screening market are also discussed thus giving a broad idea about the market to the clients.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Table Of Content:

  1. Global Blood screening Market: Research Methodology
  2. Executive Summary
  3. Strategic Recommendations
  4. Blood screening Products Outlook
  5. Global Blood screening Market: Growth and Forecast
  6. Global Blood screening Market: Company Share
  7. Global Blood screening Market: Regional Analysis
  8. North America Blood screening Market: An Analysis
  9. Europe Blood screening Market: An Analysis
  10. APAC Blood screening Market: An Analysis
  11. ROW Blood screening Market: An Analysis
  12. Global Blood screening Market: Market Dynamics
  13. Porter Five Force Analysis
  14. SWOT Analysis
  15. Competitive Landscape: Product Benchmarking
  16. Company Profiles

And More….

Get Detailed TOC At

Report Synopsis

To analyze the market size of the market and infer the key trends from it.

Comprehensive quantitative analysis of the industry is provided for the period of 2020-2027 to assist stakeholders to capitalize on the prevailing market opportunities.

Industry Chain Suppliers of Blood screening market with Contact Information

To inspect the market based on product, market share and size of the product share.

Industry Chain Suppliers of Blood screening market with Contact Information

The key findings and recommendations highlight crucial progressive industry trends in the Blood screening Market, thereby allowing players to develop effective long term strategies

Customization Available: Global Blood Screening Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.



Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475


Editor Details

  • Company:
    • CDN Newswire
Last Updated: 15-Mar-2021